ALLMedicine™ Androgenetic Alopecia Center

Jul 30th, 2021 - Women with polycystic ovary syndrome are at high cardiometabolic risk. Early-onset male-pattern baldness is considered the phenotypic equivalent of polycystic ovary syndrome in men. The aim of the present study was to assess whether early-onset an...

Jul 26th, 2021 - The current medical treatments of androgenetic alopecia (AGA) have hardly achieved a satisfying clinical improvement. Biologic regenerative therapies, such as platelet-rich plasma (PRP) injections in the scalp, have been proposed recently. This mu...

Jul 24th, 2021 - The effect of oestrogens in androgenetic alopecia (AGA) pathophysiology has not been clearly understood. However, they are considered to have a place in the AGA pathogenesis as the androgens do. The effects of estrogen occur via the estrogen recep...

Jul 23rd, 2021 - Finasteride 1 mg/day is indicated for androgen-dependent conditions such as male androgenetic alopecia (AGA). The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action, and metabolism of finasterid...

Jul 10th, 2021 - To evaluate dry eye tests and Meibomian gland functions in female androgenetic alopecia patients. Twenty left eyes of 20 female androgenetic alopecia patients (Group 1) and 20 left eyes of 20 healthy female volunteers (Group 2) were enrolled in th...

Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

Feb 17th, 2020 - This study will assess the safety, tolerability, and efficacy of SM04554 at concentrations of 0.15% and 0.25%. Improved knowledge of the changes in hair counts and immunohistochemical analysis associated with androgenetic alopecia (AGA) before and...

Jan 28th, 2020 - Background and rationale Androgenetic alopecia occurs in men and women,and is characterised by the loss of hair from the scalp in a defined pattern. Determining factors appear to be genetic predisposition coupled with the presence of sufficient ci...

Jan 13th, 2020 - The STYLE Trial is a prospective, randomized, multi-center device trial intended to evaluate the safety and efficacy of the Celution and Puregraft Systems in the processing and preparation of an autologous fat graft enriched with adipose-derived r...

Jan 2nd, 2020 - Androgenetic alopecia is the most common type of hair loss in men, and affects approximately 50 percent of Caucasian men by age 50. The condition is characterized by the progressive loss of terminal hairs on the scalp in a characteristic distribut...

Dec 24th, 2019 - This study was designed to better assess the efficacy of PRP in hair loss, we therefore propose to study interval intralesional PRP injections for patients with androgenetic alopecia (AGA). Androgenetic alopecia is the most common form of hair los...

Feb 26th, 2021 - No Food and Drug Administration–approved treatment currently exists for molluscum contagiosum, which affects an estimated 6 million people in the United States, but that could soon change, according to Leon H. Kircik, MD. Dr Leon Kircik "The treat...

Aug 7th, 2020 - In the clinical experience of Bianca Maria Piraccini, MD, dermoscopic imaging of the scalp and hair can help physicians diagnose a variety of disorders that would normally require an invasive biopsy. Dermoscopic imaging, also known as trichoscopy,...

Feb 20th, 2020 - LAHAINA, HAWAII – The list of nontraditional uses for botulinum toxin type A includes facial flushing, menopausal hot flashes, and androgenetic alopecia, Mark Rubin, MD, said at the Hawaii Dermatology Seminar provided by Global Academy for Medical.

Sep 17th, 2019 - Treatment with intradermal injections of autologous platelet-rich plasma (PRP) was associated with increased hair density in men and women with androgenetic alopecia, compared with placebo, according to a meta-analysis of seven studies. In the rep.

May 18th, 2019 - Gender-affirming hormone use was significantly associated with reports of androgenetic alopecia in transgender men, based on data from a survey of 991 individuals. Given the importance of hair in body image and gender identity, hair concerns are i.